FRANKLIN, Mass., January 31, 2023 — Cold Chain Technologies, LLC (“CCT” or “Company”), provider of thermal packaging assurance solutions for temperature-sensitive products for the life sciences industry, has announced the launch of CCT TheraShieldTM, a dedicated portfolio of products and customized services to support the cell and gene therapy industry.
CCT TheraShield is a broad range of advanced, reusable thermal packaging solutions and is directly linked to the CCT Smart SolutionsTM portal to support the needs of the cell and gene therapy industry. The recently launched CCT Smart Solutions portal offers various digital solutions to help customers plan, create, track, and optimize their shipments and is the backbone of this offering. This portfolio will be available in various temperature profiles, sizes, and has been tested against the most robust industry standards. Additionally, CCT TheraShield leverages the company’s substantial experience in managing ultra-low temperature shipments with reusable services, which were showcased throughout the distribution of the mRNA Covid-19 vaccine.
By making the conscious choice of providing these solutions in a reusable format, CCT is continuing to show their strong commitment towards driving cold chain sustainability. Previously, CCT announced a goal of reducing 60 million pounds of landfill waste by the end of 2025 and has recently celebrated their success with exceeding their interim goal ahead of schedule.
“This launch truly differentiates CCT as the partner of choice in offering comprehensive end-to-end thermal packaging assurance to our existing and new customers in the life sciences industry,” said Ranjeet Banerjee, CEO of CCT. “CCT is committed to working closely with the life sciences industry to support clinical trials, innovation, and commercialization efforts of various cell and gene therapy offerings.”
